These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 21162701

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
    Srivastava P, Abujam B, Misra R, Lawrence A, Agarwal V, Aggarwal A.
    Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
    Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D.
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
    [Abstract] [Full Text] [Related]

  • 26. Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.
    Broder A, Mowrey WB, Khan HN, Jovanovic B, Londono-Jimenez A, Izmirly P, Putterman C.
    Semin Arthritis Rheum; 2018 Feb; 47(4):545-551. PubMed ID: 28803673
    [Abstract] [Full Text] [Related]

  • 27. Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis.
    Gómez-Puerta JA, Feldman CH, Alarcón GS, Guan H, Winkelmayer WC, Costenbader KH.
    Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1453-62. PubMed ID: 25624071
    [Abstract] [Full Text] [Related]

  • 28. Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
    Kwon OC, Park JH, Lee SW, Song JJ, Park YB, Park MC.
    Yonsei Med J; 2020 Nov; 61(11):951-957. PubMed ID: 33107238
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A five consecutive years' study of renal function outcome among biopsy proven lupus nephritis patients in Southern Iran.
    Pakfetrat M, Malekmakan L, Kamranpour M, Tadayon T.
    Lupus; 2017 Sep; 26(10):1082-1088. PubMed ID: 28420065
    [Abstract] [Full Text] [Related]

  • 31. Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis.
    Pakchotanon R, Gladman DD, Su J, Urowitz MB.
    Lupus; 2018 Mar; 27(3):468-474. PubMed ID: 28857717
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Long-term renal outcomes and related risk factors of familial systemic lupus erythematosus patients with lupus nephritis
.
    Huang X, Tang Z, Wu X, Zhang L, Fan W, Zhang H, Hu W, Liu Z.
    Clin Nephrol; 2018 Oct; 90(4):262-269. PubMed ID: 29932408
    [Abstract] [Full Text] [Related]

  • 34. Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients.
    Williams W, Bhagwandass A, Sargeant LA, Shah D.
    Lupus; 2003 Oct; 12(8):640-5. PubMed ID: 12945726
    [Abstract] [Full Text] [Related]

  • 35. Outcome of childhood lupus nephritis in Saudi children.
    Al-Mayouf SM, AlAmeer A, Alfattani A, Alsonbul A.
    Saudi J Kidney Dis Transpl; 2017 Oct; 28(5):1015-1020. PubMed ID: 28937057
    [Abstract] [Full Text] [Related]

  • 36. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
    Bhavsar NA, Appel LJ, Kusek JW, Contreras G, Bakris G, Coresh J, Astor BC, AASK Study Group.
    Am J Kidney Dis; 2011 Dec; 58(6):886-93. PubMed ID: 21944667
    [Abstract] [Full Text] [Related]

  • 37. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy.
    Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A.
    J Am Soc Nephrol; 1996 Jun; 7(6):924-9. PubMed ID: 8793802
    [Abstract] [Full Text] [Related]

  • 38. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.
    Mahajan A, Amelio J, Gairy K, Kaur G, Levy RA, Roth D, Bass D.
    Lupus; 2020 Aug; 29(9):1011-1020. PubMed ID: 32571142
    [Abstract] [Full Text] [Related]

  • 39. Long-term outcome of biopsy-proven lupus nephritis in Iran.
    Fatemi A, Kazemi M, Sayedbonakdar Z, Farajzadegan Z, Karimzadeh H, Moosavi M.
    Int J Rheum Dis; 2013 Dec; 16(6):739-46. PubMed ID: 24267776
    [Abstract] [Full Text] [Related]

  • 40. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.
    Pons-Estel GJ, Alarcón GS, McGwin G, Danila MI, Zhang J, Bastian HM, Reveille JD, Vilá LM, Lumina Study Group.
    Arthritis Rheum; 2009 Jun 15; 61(6):830-9. PubMed ID: 19479701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.